Back to search
FDAFDA · Food and drugs·Recall number D-66318-001

Prolia (denosumab) Injection, 60 mg/mL, 1 x 60 mg Single Use Prefilled Syringe per carton, Rx only, Manufactured by: Amgen Manufacturing Ltd., a subsidiary of Amgen Inc., Thousand Oaks, CA 91320-1799,NDC 55513-710-01, UPC 3 55513 71001 5.

Published November 13, 2013 · Recall initiated: September 17, 2013

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Visible cellulose fibers were observed in a small number of prefilled syringes during a routine quality examination.

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
PROLIA
Manufacturer
Amgen, Inc.
Distributor
Nationwide and Puerto Rico, Canada, Mexico, and clinical distribution in Europe.
UPC
355513710015
Lot
Lot #: 1037592, Exp 07/15
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card